The Balancing Act® Airing on Lifetime TV Discusses Biomarker Testing in Lung Cancer
Boehringer Ingelheim Sponsors Segment on March 21st Show to Help Raise Awareness of Biomarker Testing in Lung Cancer(Pompano Beach, FL – CISION – March 20, 2013) Award-winning popular morning show The Balancing Act®, airing on Lifetime® TV, will feature a segment sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. to discuss biomarker testing in lung cancer on Friday, March 21 at 7:00 a.m. (ET/PT). Make sure to tune in as The Balancing Act hosts help jump start the day with animated conversation and trusted information to empower a woman’s life. Don’t miss this featured segment